Matthew E. Tenold

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Outcomes of Adults With Relapsed/Refractory Acute Myeloid Leukemia Treated With Venetoclax Plus Hypomethylating Agents at a Comprehensive Cancer Center”.

Outcomes of Adults With Relapsed/Refractory Acute Myeloid Leukemia Treated With Venetoclax Plus Hypomethylating Agents at a Comprehensive Cancer Center

Frontiers in Oncology(2021)10.3389/fonc.2021.649209

N/A

0.606DataRank · unranked

56 citations

Benjamin N. Moskoff, David J. Benjamin, Rasmus T. Hoeg, Aaron S. Rosenberg, Mehrdad Abedi +3 more

Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center

Leukemia Research(2022)10.1016/j.leukres.2022.106885

N/A

0DataRank · unranked

8 citations

Benjamin Moskoff, Gwendolyn Ho, Matthew E. Tenold, Tali Azenkot, Margaret L. Krackeler +12 more